Shenzhu Guanxin Recipe Granules (参术冠心方颗粒) for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter,Randomized, Double-Blind,Placebo Parallel Controlled Clinical Trial |
| |
作者姓名: | MAO Shuai XU Dan-ping DANG Xiao-jing LI Winny WU Huan-lin |
| |
作者单位: | Second Clinical Medical College;Heart Center;Faculty of Medicine;Beijing University of Chinese Medicine |
| |
基金项目: | Supported by Foundation from Department of Science and Technology of Guangdong Province(No.2012A032500017);Foundation from Guangdong Provincial Academy of Traditional Chinese Medicine(No.YN2014LN07,YK2013B1N10,A2016192);Science Foundation of Guangdong Province(No.2015A030310437,2015A030306049);National Natural Science Foundation(No.81403341,81703877) |
| |
摘 要: | Background:Manypatientswithchronicanginaexperienceanginalepisodesdespitesuccessfulrecanalization,antianginalandantiischemicmedications.EmpiricalobservationssuggestedthatShenzhuGuanxinRecipeGranules(参术冠心方颗粒,SGR),aChineseherbalcompound,exertedpotentialimpactsonincreasedtreadmillexerciseperformanceandanginarelieve.However,therehasbeennosystematicstudytoclarifytheimpactofSGRonexercisetoleranceinpatientswithstableangina.TheSERIES(ShEnzhuguanxinRecipeforImprovingExercisetoleranceinpatientswithStableangina)trialisdesignedtodeterminetheeffectsofSGRonexerciseduration,electrocardiographic(ECG)evidenceofmyocardialischemia,andincidenceofmajoradversecardiacevents(MACE)instableanginalpatients.Methods:Atotalof184eligiblepatientswithstableanginawillberandomlyassignedtoreceiveplaceboorSGR(10g/dayfor12weeks)ina1:1ratio.Theprimaryoutcomewillbethechangefrombaselineintotalexercisetoleranceduration,timetoonsetofanginaandECGischemiaduringexercisetreadmilltestingperformedovera12-weekstudyperiod.ThesecondaryoutcomewillincludeECGmeasures,theoccurrenceandcompositeofMACEandtheSeattleAnginaQuestionnairescore.Moreover,thecoronarymicrocirculationwillbeevaluatedtoexplorethepossibleeffectsinresponsetotreatmentofSGR.Aftertheprocedure,allparticipantswillbefollowedupbyinterviewat3and6months,enquiringaboutanycardiacevents,hospitalizations,cardiacfunctionallevelandmedicationusage.Additionally,theoccurrenceofadverseeventswillbeevaluatedateachfollow-up.Discussion:ThisstudymayprovidenovelevidenceontheefficacyofSGRinimprovingexercisetoleranceandpotentiallyreducingclinicaladverseevents.(TrialregistrationNo.ChiCTR-TRC-14004504)
|
关 键 词: | exercise tolerance stable angina Shenzhu Guanxin RECIPE coronary microcirculation TRIAL PROTOCOL RANDOMIZED controlled TRIAL |
本文献已被 CNKI 维普 等数据库收录! |
| 点击此处可从《中国结合医学杂志》浏览原始摘要信息 |
|
点击此处可从《中国结合医学杂志》下载全文 |
|